Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Applied Therapeutics Inc buy BiotechBee

Applied Therapeutics Inc
Start price
€5.80
18.02.24 / 60%
Target price
€4.00
31.01.26
Performance (%)
-58.59%
End price
€2.40
28.11.24
Summary
This prediction ended on 28.11.24 with a price of €2.40. Massive losses of -58.59% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Applied Therapeutics Inc - - -
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

According to BiotechBee what are the pros and cons of Applied Therapeutics Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Applied Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -58.59%
Target price 4.000
Change
Ends at 31.01.26

Buy mit Kursziel 4,0

BiotechBee 
0
Report Share
18.02.24
In the thread Trading Applied Therapeutics Inc
Prediction Buy
Perf. (%) -58.59%
Target price 4.000
Change
Ends at 31.01.26

Buy beendet

BiotechBee 
0
Report Share
28.11.24

Stopped prediction by BiotechBee for Applied Therapeutics Inc

buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€2.67
24.12.23
€5.00
31.08.25
-16.32%
05.01.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.12.23 50%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€2.75
10.12.23
€3.50
31.03.26
-3.09%
24.12.23

Could be very worthwhile Investment >20% year
BiotechBee 
10.12.23 50%